 | • レポートコード：QYR2104Z0032 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、末端黒子型黒色腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、粉末、その他）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・末端黒子型黒色腫治療の市場動向 ・企業の競争状況、市場シェア ・末端黒子型黒色腫治療の種類別市場規模（注射、粉末、その他） ・末端黒子型黒色腫治療の用途別市場規模（病院、薬局） ・末端黒子型黒色腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・末端黒子型黒色腫治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・末端黒子型黒色腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・末端黒子型黒色腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・末端黒子型黒色腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Chiron Corporation、Prometheus Laboratories） ・結論 |
Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene.
Market Analysis and Insights: Global Acral Lentiginous Melanoma Treatment Market
The global Acral Lentiginous Melanoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acral Lentiginous Melanoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acral Lentiginous Melanoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acral Lentiginous Melanoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acral Lentiginous Melanoma Treatment market.
Global Acral Lentiginous Melanoma Treatment Scope and Market Size
Acral Lentiginous Melanoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acral Lentiginous Melanoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Injection
Powder
Other
Segment by Application
Hospital
Pharmacy
By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
レポート目次1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acral Lentiginous Melanoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Powder
1.2.4 Other
1.3 Market by Application
1.3.1 Global Acral Lentiginous Melanoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Acral Lentiginous Melanoma Treatment Market Perspective (2016-2027)
2.2 Acral Lentiginous Melanoma Treatment Growth Trends by Regions
2.2.1 Acral Lentiginous Melanoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acral Lentiginous Melanoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Acral Lentiginous Melanoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Acral Lentiginous Melanoma Treatment Industry Dynamic
2.3.1 Acral Lentiginous Melanoma Treatment Market Trends
2.3.2 Acral Lentiginous Melanoma Treatment Market Drivers
2.3.3 Acral Lentiginous Melanoma Treatment Market Challenges
2.3.4 Acral Lentiginous Melanoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acral Lentiginous Melanoma Treatment Players by Revenue
3.1.1 Global Top Acral Lentiginous Melanoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Acral Lentiginous Melanoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Acral Lentiginous Melanoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acral Lentiginous Melanoma Treatment Revenue
3.4 Global Acral Lentiginous Melanoma Treatment Market Concentration Ratio
3.4.1 Global Acral Lentiginous Melanoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acral Lentiginous Melanoma Treatment Revenue in 2020
3.5 Acral Lentiginous Melanoma Treatment Key Players Head office and Area Served
3.6 Key Players Acral Lentiginous Melanoma Treatment Product Solution and Service
3.7 Date of Enter into Acral Lentiginous Melanoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acral Lentiginous Melanoma Treatment Breakdown Data by Type
4.1 Global Acral Lentiginous Melanoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Acral Lentiginous Melanoma Treatment Forecasted Market Size by Type (2022-2027)
5 Acral Lentiginous Melanoma Treatment Breakdown Data by Application
5.1 Global Acral Lentiginous Melanoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Acral Lentiginous Melanoma Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Acral Lentiginous Melanoma Treatment Market Size (2016-2027)
6.2 North America Acral Lentiginous Melanoma Treatment Market Size by Type
6.2.1 North America Acral Lentiginous Melanoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Acral Lentiginous Melanoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Acral Lentiginous Melanoma Treatment Market Size by Type (2016-2027)
6.3 North America Acral Lentiginous Melanoma Treatment Market Size by Application
6.3.1 North America Acral Lentiginous Melanoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Acral Lentiginous Melanoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Acral Lentiginous Melanoma Treatment Market Size by Application (2016-2027)
6.4 North America Acral Lentiginous Melanoma Treatment Market Size by Country
6.4.1 North America Acral Lentiginous Melanoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Acral Lentiginous Melanoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Acral Lentiginous Melanoma Treatment Market Size (2016-2027)
7.2 Europe Acral Lentiginous Melanoma Treatment Market Size by Type
7.2.1 Europe Acral Lentiginous Melanoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Acral Lentiginous Melanoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Acral Lentiginous Melanoma Treatment Market Size by Type (2016-2027)
7.3 Europe Acral Lentiginous Melanoma Treatment Market Size by Application
7.3.1 Europe Acral Lentiginous Melanoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Acral Lentiginous Melanoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Acral Lentiginous Melanoma Treatment Market Size by Application (2016-2027)
7.4 Europe Acral Lentiginous Melanoma Treatment Market Size by Country
7.4.1 Europe Acral Lentiginous Melanoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Acral Lentiginous Melanoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size by Type
8.2.1 Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size by Application
8.3.1 Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size by Region
8.4.1 Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Acral Lentiginous Melanoma Treatment Market Size (2016-2027)
9.2 Latin America Acral Lentiginous Melanoma Treatment Market Size by Type
9.2.1 Latin America Acral Lentiginous Melanoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Acral Lentiginous Melanoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Acral Lentiginous Melanoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Acral Lentiginous Melanoma Treatment Market Size by Application
9.3.1 Latin America Acral Lentiginous Melanoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Acral Lentiginous Melanoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Acral Lentiginous Melanoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Acral Lentiginous Melanoma Treatment Market Size by Country
9.4.1 Latin America Acral Lentiginous Melanoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Acral Lentiginous Melanoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size by Type
10.2.1 Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size by Application
10.3.1 Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size by Country
10.4.1 Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Chiron Corporation
11.1.1 Chiron Corporation Company Details
11.1.2 Chiron Corporation Business Overview
11.1.3 Chiron Corporation Acral Lentiginous Melanoma Treatment Introduction
11.1.4 Chiron Corporation Revenue in Acral Lentiginous Melanoma Treatment Business (2016-2021)
11.1.5 Chiron Corporation Recent Development
11.2 Prometheus Laboratories
11.2.1 Prometheus Laboratories Company Details
11.2.2 Prometheus Laboratories Business Overview
11.2.3 Prometheus Laboratories Acral Lentiginous Melanoma Treatment Introduction
11.2.4 Prometheus Laboratories Revenue in Acral Lentiginous Melanoma Treatment Business (2016-2021)
11.2.5 Prometheus Laboratories Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Acral Lentiginous Melanoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injection
Table 3. Key Players of Powder
Table 4. Key Players of Other
Table 5. Global Acral Lentiginous Melanoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Acral Lentiginous Melanoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Acral Lentiginous Melanoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Acral Lentiginous Melanoma Treatment Market Share by Regions (2016-2021)
Table 9. Global Acral Lentiginous Melanoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Acral Lentiginous Melanoma Treatment Market Share by Regions (2022-2027)
Table 11. Acral Lentiginous Melanoma Treatment Market Trends
Table 12. Acral Lentiginous Melanoma Treatment Market Drivers
Table 13. Acral Lentiginous Melanoma Treatment Market Challenges
Table 14. Acral Lentiginous Melanoma Treatment Market Restraints
Table 15. Global Acral Lentiginous Melanoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Acral Lentiginous Melanoma Treatment Market Share by Players (2016-2021)
Table 17. Global Top Acral Lentiginous Melanoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acral Lentiginous Melanoma Treatment as of 2020)
Table 18. Ranking of Global Top Acral Lentiginous Melanoma Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Acral Lentiginous Melanoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Acral Lentiginous Melanoma Treatment Product Solution and Service
Table 22. Date of Enter into Acral Lentiginous Melanoma Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Acral Lentiginous Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Acral Lentiginous Melanoma Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Acral Lentiginous Melanoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Acral Lentiginous Melanoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Acral Lentiginous Melanoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Acral Lentiginous Melanoma Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Acral Lentiginous Melanoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Acral Lentiginous Melanoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Acral Lentiginous Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Acral Lentiginous Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Acral Lentiginous Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Acral Lentiginous Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Acral Lentiginous Melanoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Acral Lentiginous Melanoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Acral Lentiginous Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Acral Lentiginous Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Acral Lentiginous Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Acral Lentiginous Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Acral Lentiginous Melanoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Acral Lentiginous Melanoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Acral Lentiginous Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Acral Lentiginous Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Acral Lentiginous Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Acral Lentiginous Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Acral Lentiginous Melanoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Acral Lentiginous Melanoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Chiron Corporation Company Details
Table 63. Chiron Corporation Business Overview
Table 64. Chiron Corporation Acral Lentiginous Melanoma Treatment Product
Table 65. Chiron Corporation Revenue in Acral Lentiginous Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 66. Chiron Corporation Recent Development
Table 67. Prometheus Laboratories Company Details
Table 68. Prometheus Laboratories Business Overview
Table 69. Prometheus Laboratories Acral Lentiginous Melanoma Treatment Product
Table 70. Prometheus Laboratories Revenue in Acral Lentiginous Melanoma Treatment Business (2016-2021) & (US$ Million)
Table 71. Prometheus Laboratories Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acral Lentiginous Melanoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Injection Features
Figure 3. Powder Features
Figure 4. Other Features
Figure 5. Global Acral Lentiginous Melanoma Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Pharmacy Case Studies
Figure 8. Acral Lentiginous Melanoma Treatment Report Years Considered
Figure 9. Global Acral Lentiginous Melanoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Acral Lentiginous Melanoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Acral Lentiginous Melanoma Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Acral Lentiginous Melanoma Treatment Market Share by Regions (2022-2027)
Figure 13. Global Acral Lentiginous Melanoma Treatment Market Share by Players in 2020
Figure 14. Global Top Acral Lentiginous Melanoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acral Lentiginous Melanoma Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Acral Lentiginous Melanoma Treatment Revenue in 2020
Figure 16. Global Acral Lentiginous Melanoma Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Acral Lentiginous Melanoma Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Acral Lentiginous Melanoma Treatment Market Share by Type (2016-2027)
Figure 20. North America Acral Lentiginous Melanoma Treatment Market Share by Application (2016-2027)
Figure 21. North America Acral Lentiginous Melanoma Treatment Market Share by Country (2016-2027)
Figure 22. United States Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Acral Lentiginous Melanoma Treatment Market Share by Type (2016-2027)
Figure 26. Europe Acral Lentiginous Melanoma Treatment Market Share by Application (2016-2027)
Figure 27. Europe Acral Lentiginous Melanoma Treatment Market Share by Country (2016-2027)
Figure 28. Germany Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Acral Lentiginous Melanoma Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Acral Lentiginous Melanoma Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Acral Lentiginous Melanoma Treatment Market Share by Region (2016-2027)
Figure 38. China Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Acral Lentiginous Melanoma Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Acral Lentiginous Melanoma Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Acral Lentiginous Melanoma Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Acral Lentiginous Melanoma Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Acral Lentiginous Melanoma Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Acral Lentiginous Melanoma Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Acral Lentiginous Melanoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Chiron Corporation Revenue Growth Rate in Acral Lentiginous Melanoma Treatment Business (2016-2021)
Figure 58. Prometheus Laboratories Revenue Growth Rate in Acral Lentiginous Melanoma Treatment Business (2016-2021)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
世界の化学療法薬誘発性肢端紅斑（手足症候群）治療市場規模・現状・予測（2021年-2027年） Acral erythema, also called as hand-foot syndrome or palmar-plantar erythrodysesthesia, is characterized by swelling, redness, paraesthesia (numbness) and desquamation (skin peeling) of palms, soles and rarely on knees and elbow. Acryl erythema is an adverse drug reaction which typically appear afte…- 世界の化学療法薬誘発性肢端紅斑（手足症候群）治療市場規模・現状・予測（2021年-2027年） Acral erythema, also called as hand-foot syndrome or palmar-plantar erythrodysesthesia, is characterized by swelling, redness, paraesthesia (numbness) and desquamation (skin peeling) of palms, soles and rarely on knees and elbow. Acryl erythema is an adverse drug reaction which typically appear afte…
- 世界の非黒色腫皮膚がん治療市場規模・現状・予測（2021年-2027年） Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlike…
- 世界の黒色腫市場規模・現状・予測（2021年-2027年） Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are mo…
- 世界の黒色腫市場規模・現状・予測（2021年-2027年） Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are mo…